This study is not yet accepting patients

The Effects of Audio-Based Therapy on Anxiety in Psoriasis

a study on Psoriasis Anxiety

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by Wilson Liao, MD
Headshot of Wilson Liao
Wilson Liao

Description

Summary

Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.

Keywords

Psoriasis (PsO), Anxiety, Surveys and Questionnaires, Acoustic Stimulation, Complementary Therapies, Psoriasis, Anxiety Disorders, Music Therapy, Pink Noise

Eligibility

You can join if…

Open to people ages 18 years and up

  • Age ≥18 years
  • Self-reported dermatologist-diagnosed psoriasis
  • GAD 2-Item Score ≥1 at screening
  • Ability to consent and complete pre- and post-intervention surveys.
  • Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.

You CAN'T join if...

  • Severe hearing impairment precluding headphone listening
  • Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe.
  • Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.

Location

  • Liao Lab at UCSF
    San Francisco California 94115 United States

Lead Scientist at UCSF

  • Wilson Liao, MD
    Dr. Liao is Professor and Associate Vice Chair of Research in the UCSF Department of Dermatology. He serves as Director of the UCSF Psoriasis and Skin Treatment Center and is deeply engaged in patient care, clinical trials, and translational research.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07390487
Study Type
Interventional
Participants
Expecting 120 study participants
Last Updated